import type { Trial } from "./types";

export const data: Trial[] = [
  {
    id: 1,
    name: "SELCLAX",
    title:
      "Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia",
    description:
      "The purpose of this study is to test the safety and determine the best dose of venetoclax and selinexor when given with chemotherapy drugs in treating pediatric and young adult patients with acute myeloid leukemia (AML) or acute leukemia of ambiguous lineage (ALAL) that has come back (relapsed) or did not respond to treatment (refractory).",
    location: "St. Jude Children's Research Hospital",
    url: "https://clinicaltrials.gov/ct2/show/NCT04898894",
    additionalInfo: {
      title: "Pediatric Clinical Trial Nurse Navigator One-on-One Support",
      description:
        "To connect with a Pediatric Clinical Trial Nurse Navigator at the Leukemia & Lymphoma Society who will personally assist your patient throughout the entire clinical-trial process, click this link to fill out a Clinical Trial Support Center referral form  . One of our pediatric oncology nurses will call your patient within 1 business day and provide you with a copy of the individualized trial search results. For general inquiries, simply email askPedAL@lls.org  .",
    },
  },
  {
    id: 2,
    name: "PEDSHEMAML0007",
    title: "Niclosamide in Pediatric Patients With Relapsed and Refractory AML",
    description: "",
    location: "",
    url: "",
  },
  {
    id: 3,
    name: "RHM CHI0811",
    title:
      "Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma (MiniVan)",
    description: "",
    location: "",
    url: "",
  },
  {
    id: 4,
    name: "19-680",
    title: "GVAX Plus Checkpoint Blockade in Neuroblastoma",
    description: "",
    location: "",
    url: "",
  },
  {
    id: 5,
    name: "APAL2020SC",
    title:
      "A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat",
    description: "",
    location: "",
    url: "",
  },
];
